Imprinting defects at human 14q32 locus alters gene expression and is associated with the pathobiology of osteosarcoma

Osteosarcoma is the most common primary bone malignancy affecting children and adolescents. Although several genetic predisposing conditions have been associated with osteosarcoma, our understanding of its pathobiology is rather limited. Here we show that, first, an imprinting defect at human 14q32-locus is highly prevalent (87%) and specifically associated with osteosarcoma patients < 30 years of age. Second, the average demethylation at differentially methylated regions (DMRs) in the 14q32-locus varied significantly compared to genome-wide demethylation. Third, the 14q32-locus was enriched in both H3K4-me3 and H3K27-me3 histone modifications that affected expression of all imprinted genes and miRNAs in this region. Fourth, imprinting defects at 14q32 - DMRs are present in triad DNA samples from affected children and their biological parents. Finally, imprinting defects at 14q32-DMRs were also observed at higher frequencies in an Rb1/Trp53 mutation-induced osteosarcoma mouse model. Further analysis of normal and tumor tissues from a Sleeping Beauty mouse model of spontaneous osteosarcoma supported the notion that these imprinting defects may be a key factor in osteosarcoma pathobiology. In conclusion, we demonstrate that imprinting defects at the 14q32 locus significantly alter gene expression, may contribute to the pathogenesis of osteosarcoma, and could be predictive of survival outcomes.

[1]  A. Feinberg,et al.  Loss of imprinting of IGF2: a common epigenetic modifier of intestinal tumor risk. , 2005, Cancer research.

[2]  T. Ogata,et al.  Epimutations of the IG-DMR and the MEG3-DMR at the 14q32.2 imprinted region in two patients with Silver–Russell Syndrome-compatible phenotype , 2014, European Journal of Human Genetics.

[3]  Cole Trapnell,et al.  TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions , 2013, Genome Biology.

[4]  I. Rigoutsos,et al.  The microRNAs within the DLK1-DIO3 genomic region: involvement in disease pathogenesis , 2012, Cellular and Molecular Life Sciences.

[5]  S. Friend,et al.  Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma , 1992 .

[6]  W. Wallace,et al.  Twentieth-century survival from osteosarcoma in childhood. Trends from 1933 to 2004. , 2007, The Journal of bone and joint surgery. British volume.

[7]  Kevin B. Jones.  Transposon mutagenesis disentangles osteosarcoma genetic drivers , 2015, Nature Genetics.

[8]  M. Bouxsein,et al.  Metastatic osteosarcoma induced by inactivation of Rb and p53 in the osteoblast lineage , 2008, Proceedings of the National Academy of Sciences.

[9]  S. Takada,et al.  Restricted co-expression of Dlk1 and the reciprocally imprinted non-coding RNA, Gtl2: implications for cis-acting control. , 2007, Developmental biology.

[10]  P. Picci,et al.  Alteration of pRb/p16/cdk4 regulation in human osteosarcoma , 1999, International journal of cancer.

[11]  G. Gyapay,et al.  Human-ovine comparative sequencing of a 250-kb imprinted domain encompassing the callipyge (clpg) locus and identification of six imprinted transcripts: DLK1, DAT, GTL2, PEG11, antiPEG11, and MEG8. , 2001, Genome research.

[12]  M. Surani,et al.  Parental origin-specific developmental defects in mice with uniparental disomy for chromosome 12. , 2000, Development.

[13]  C. Plass,et al.  Loss of imprinting of the insulin-like growth factor II gene occurs by biallelic methylation in a core region of H19-associated CTCF-binding sites in colorectal cancer. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Kevin B. Jones,et al.  The impact of osteoblastic differentiation on osteosarcomagenesis in the mouse , 2014, Oncogene.

[15]  Natalie K. Wolf,et al.  A Sleeping Beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasis , 2015, Nature Genetics.

[16]  M. Eccles,et al.  Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour , 1993, Nature.

[17]  H. Okabe,et al.  Imprinted DLK1 is a putative tumor suppressor gene and inactivated by epimutation at the region upstream of GTL2 in human renal cell carcinoma. , 2006, Human molecular genetics.

[18]  J. Issa,et al.  A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. , 2004, Nucleic acids research.

[19]  M. Eccles,et al.  Constitutional relaxation of insulin–like growth factor II gene imprinting associated with Wilms' tumour and gigantism , 1993, Nature Genetics.

[20]  Hyung‐Ho Kim,et al.  Aberrant Methylation of p14ARF Gene Correlates with Poor Survival in Osteosarcoma , 2006, Clinical orthopaedics and related research.

[21]  Cole Trapnell,et al.  Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. , 2010, Nature biotechnology.

[22]  G. Wright,et al.  A Role for the Retinoblastoma Protein As a Regulator of Mouse Osteoblast Cell Adhesion: Implications for Osteogenesis and Osteosarcoma Formation , 2010, PloS one.

[23]  A. Cleton-Jansen,et al.  MicroRNAs at the human 14q32 locus have prognostic significance in osteosarcoma , 2013, Orphanet Journal of Rare Diseases.

[24]  D. Papatsenko,et al.  Modeling Familial Cancer with Induced Pluripotent Stem Cells , 2015, Cell.

[25]  E. Hatzimichael,et al.  MEG3 imprinted gene contribution in tumorigenesis , 2011, International journal of cancer.

[26]  H. Sul,et al.  Mice Lacking Paternally Expressed Pref-1/Dlk1 Display Growth Retardation and Accelerated Adiposity , 2002, Molecular and Cellular Biology.

[27]  A. Ferguson-Smith,et al.  Epigenetic alteration at the DLK1-GTL2 imprinted domain in human neoplasia: analysis of neuroblastoma, phaeochromocytoma and Wilms' tumour , 2005, British Journal of Cancer.

[28]  W. Reik,et al.  Genomic imprinting: parental influence on the genome , 2001, Nature Reviews Genetics.

[29]  Wei Li,et al.  Activation of the Imprinted Dlk1-Dio3 Region Correlates with Pluripotency Levels of Mouse Stem Cells , 2010, The Journal of Biological Chemistry.

[30]  S. Murphy,et al.  Novel imprinted DLK1/GTL2 domain on human chromosome 14 contains motifs that mimic those implicated in IGF2/H19 regulation. , 2000, Genome research.

[31]  S. Bielack,et al.  Determination of the prognostic value of loss of heterozygosity at the retinoblastoma gene in osteosarcoma. , 2007, International journal of oncology.

[32]  Martina Paulsen,et al.  Identification of tandemly-repeated C/D snoRNA genes at the imprinted human 14q32 domain reminiscent of those at the Prader-Willi/Angelman syndrome region. , 2002, Human molecular genetics.

[33]  Kenichi Harada,et al.  Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines , 2002, Oncogene.

[34]  A. Green,et al.  The IG-DMR and the MEG3-DMR at Human Chromosome 14q32.2: Hierarchical Interaction and Distinct Functional Properties as Imprinting Control Centers , 2010, PLoS genetics.

[35]  K. Janeway,et al.  Sequelae of osteosarcoma medical therapy: a review of rare acute toxicities and late effects. , 2010, The Lancet. Oncology.

[36]  L. Benetatos,et al.  DLK1-MEG3 imprinted domain microRNAs in cancer biology. , 2012, Critical reviews in eukaryotic gene expression.

[37]  S. Baylin,et al.  Inactivation of CACNA1G, a T-type calcium channel gene, by aberrant methylation of its 5' CpG island in human tumors. , 1999, Cancer research.

[38]  Kenji Nakamura,et al.  Role of retrotransposon-derived imprinted gene, Rtl1, in the feto-maternal interface of mouse placenta , 2008, Nature Genetics.

[39]  M. Toyota,et al.  CpG island methylator phenotypes in aging and cancer. , 1999, Seminars in cancer biology.

[40]  M. Ladanyi,et al.  Loss of imprinting of IGF2 and H19 in osteosarcoma is accompanied by reciprocal methylation changes of a CTCF-binding site. , 2003, Human molecular genetics.

[41]  D. Kotzot.  Maternal uniparental disomy 14 dissection of the phenotype with respect to rare autosomal recessively inherited traits, trisomy mosaicism, and genomic imprinting. , 2004, Annales de genetique.

[42]  A. Feinberg,et al.  The genetics of BWS associated tumors , 1999 .

[43]  P. Becker,et al.  Preparation of chromatin assembly extracts from preblastoderm Drosophila embryos. , 2009, Methods in molecular biology.

[44]  T. Jacks,et al.  Mutant p53 Gain of Function in Two Mouse Models of Li-Fraumeni Syndrome , 2004, Cell.

[45]  L. Mirabello,et al.  Osteosarcoma incidence and survival rates from 1973 to 2004 , 2009, Cancer.

[46]  J. Issa,et al.  Repetitive elements and enforced transcriptional repression co-operate to enhance DNA methylation spreading into a promoter CpG-island , 2012, Nucleic acids research.

[47]  M. Surani,et al.  Imprinting and the Epigenetic Asymmetry Between Parental Genomes , 2001, Science.

[48]  A. Ferguson-Smith,et al.  Deletions and epimutations affecting the human 14q32.2 imprinted region in individuals with paternal and maternal upd(14)-like phenotypes , 2008, Nature Genetics.

[49]  J. Issa,et al.  Silencing of bidirectional promoters by DNA methylation in tumorigenesis. , 2006, Cancer research.

[50]  T. Jensen,et al.  Regulation of Human Skeletal Stem Cells Differentiation by Dlk1/Pref‐1 , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[51]  R. Feil,et al.  Genomic imprinting in mammals: an interplay between chromatin and DNA methylation? , 1999, Trends in genetics : TIG.

[52]  T. Jensen,et al.  Dlk1/FA1 is a novel endocrine regulator of bone and fat mass and its serum level is modulated by growth hormone. , 2007, Endocrinology.

[53]  Toshiro K. Ohsumi,et al.  Genome-wide identification of polycomb-associated RNAs by RIP-seq. , 2010, Molecular cell.

[54]  V. Thayanithy,et al.  Perturbation of 14q32 miRNAs-cMYC gene network in osteosarcoma. , 2012, Bone.

[55]  N. Chandar,et al.  Inactivation of p53 gene in human and murine osteosarcoma cells. , 1992, British Journal of Cancer.

[56]  H. Sul,et al.  Pref-1 regulates mesenchymal cell commitment and differentiation through Sox9. , 2009, Cell metabolism.

[57]  David M. Thomas,et al.  Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in mice. , 2009, The Journal of clinical investigation.

[58]  Subbaya Subramanian,et al.  Downregulation of microRNAs miR-1, -206 and -29 stabilizes PAX3 and CCND2 expression in rhabdomyosarcoma , 2012, Laboratory Investigation.